AzTrials
AzTrials

Lisfranc InjuryNCT05799807

Weight-bearing Diagnostics in Acute Lisfranc Injury: CT vs X-ray

A study testing Conservative treatment and Minimally invasive stabilization in people with Lisfranc Injury and Foot Sprain, run by Oslo University Hospital at 1 site in Norway.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

A prospective, cohort study comparing weight-bearing computed tomography with weight-bearing radiography in patients with an acute Lisfranc injury. Read more about this study

Who is it for?
Ages 18 to 70 yearsHealthy volunteers can take part
Conditions the study is for
Lisfranc Injury, Foot Sprain
What is being tested?
Conservative treatment and Minimally invasive stabilization
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
38 participants
Where
1 siteNorway
Study dates
18 Apr 2023to 30 Jun 2025
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 70 years
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Acute trauma to the midfoot
  • Intraarticular fracture and/or avulsion fracture in the TMT joint line (detected on a non-weight-bearing CT)
  • Suspicion of a purely ligamentous Lisfranc injury (no radiological fractures but substantial clinical findings in the midfoot region, or evidence of ligamentous damage on a MRI)
  • Consent-competent patient

Who cannot join

  • Obvious acute unstable Lisfranc injuries (>2mm dislocation between the medial cuneiform and second metatarsal)
  • Injury older than four weeks
  • Other major foot/ankle/leg injuries
  • Previous foot infection or foot pathology on the affected side
  • Previous surgery to the TMT joints, and sequelae after a previous foot injury
  • Open injury
  • Bilateral injury
  • Patients with co-morbidities such as neuropathy and peripheral vascular disease

Trial locations and contacts

1 site in 1 country.

Norway1 site
  • Oslo University Hospital, Ullevål

    Oslo, 0450

Other trials in Norway

About this study

Official title: Weight-bearing Diagnostics in Acute Lisfranc Injury: A Prospective Study Comparing Computed Tomography Versus Conventional Radiography

A prospective, cohort study comparing weight-bearing computed tomography with weight-bearing radiography in patients with an acute Lisfranc injury.

Read the detailed description

Injury to the tarsometatarsal (TMT) joint complex in the midfoot is referred to as a Lisfranc injury. The broad spectrum of these injuries includes simple sprains to severe fracture-dislocations. Variable clinical presentations and radiographic findings make Lisfranc injuries notoriously difficult to detect, especially in the case of subtle ligament injuries. Nowadays, up to 30% of unstable Lisfranc injuries are overlooked or misdiagnosed. This can potentially lead to severe sequelae such as post-traumatic osteoarthritis and foot deformities.

For obvious injuries involving diastasis, subluxation, or dislocation, the diagnosis is relatively easy to establish using any imaging modality. However, for subtle injuries without gross bone separation, a dynamic imaging modality facilitating weight-bearing are to be preferred. Many consider weight-bearing conventional radiography as the current gold standard in acute Lisfranc injury diagnostics. However, conventional radiography is a 2D technique that can neither display nor measure the true dimensions of a detailed 3D object, such as the tarsal bones in the foot. Computed tomography (CT) provides greater accuracy in visualizing bone microarchitecture. In combination with weight-bearing, it can be ideal for detecting minor fractures and occult instability caused by load/stress.

To this day, there are no prospective studies comparing weight-bearing CT and weight-bearing radiography for acute Lisfranc injuries. In the current study, participants will be assigned to non-operative or operative treatment based on Lisfranc joint stability evaluation by the initial weight-bearing CT.

Being tested
Conservative treatment, Minimally invasive stabilization

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Conservative treatmentProcedure or surgery

    Patients with negativ weight-bearing CT will be treated conservative

  • Minimally invasive stabilizationProcedure or surgery

    Patients with positive weight-bearing CT will be operated by minimally invasive stabilization (eg, isolated homerun screw)

Study groups in NCT05799807
Study groupRoleWhat they receive
Cohort 1 - ConservativeActive comparatorNegative weight-bearing CT (≤ 2mm between C1-M2, as opposed to the uninjured side) will be considered stable and treated conservatively with a prefabricated walker with weight-bearing as tolerated for six weeks. These patients will undergo bilateral radiographs after six weeks and combined CT and radiographs after twelve weeks to monitor the degree of stability
Receives: Procedure: Conservative treatment
Cohort 2 - SurgicalActive comparatorPositive weight-bearing CT (> 2mm between C1-M2, as opposed to the uninjured side) will be operated by minimally invasive stabilization (eg, isolated homerun screw)
Receives: Procedure: Minimally invasive stabilization

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Manchester-Oxford Foot Questionnaire (MOxFQ)

    Foot-Ankle specific PROM (0-100 with 0 representing the best possible outcome)

    Measured: 1 year

Secondary outcomes (5)
  1. American Orthopaedic Foot and Ankle Society (AOFAS) Ankle-Midfoot score

    Foot-Ankle specific PROM (0-48 with 48 representing the best possible outcome)

    Measured: 1 year

  2. Visual Analogue Scale (VAS) for pain

    Scores pain at rest and on activity (0-10 with 0 representing no pain)

    Measured: 1 year

  3. Short-Form (SF) 36

    Patient reported score measuring quality of life and health status (0-100 with 100 representing the best possible outcome)

    Measured: 1 year

  4. Posttraumatic osteoarthritis

    The presence of osteoarthritis of the tarsometatarsal joints using the Kellgren \& Lawrence classification system

    Measured: 1 year

  5. Incidence of complications

    Yes/no for deep or superficial infection, nerve or tendon injury, deep venous thrombosis, hardware complaints and secondary surgery. Regards the patients that have undergone surgical treatment.

    Measured: 1 year

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted5 Apr 2023
  2. Study start18 Apr 2023
  3. Primary completion30 Apr 2024
  4. Study completion30 Jun 2025 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Diagnosis
Allocation
Non-randomised
Intervention model
Parallel groups
Model description
Acute Lisfranc injuries are investigated with weight-bearing diagnostics to determine the degree of TMT stability. Patients are examined using both CT and conventional radiography during full weight and non-weight-bearing sequences. 3 foot- and ankle surgeons will examine the scans independently, starting with the conventional radiographs. Distance between the medial cuneiform and second metatarsal bone (C1-M2) is measured. For the CT images, measuring method previously described by Y. Sripanich et al. (DOI: 10.1007/s00402-020-03477-5) will be used. CT findings will determine the treatment outcome. If the C1-M2 diastasis is \>2mm, as opposed to the uninjured side, the injury will be determined unstable and surgical fixation will be recommended (Cohort 2). All other patients (≤ 2mm) are considered stable and treated conservatively (Cohort 1).
Masking
None (open label)
Enrolment
38 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05799807
Sponsor's protocol ID
110364
Status last verified
Jun 2024
First submitted
23 Mar 2023
Last updated
27 Jun 2024
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Poulsen M, Rohrl SM, Schulz A, Stodle AH. Prospective Validation of a Weightbearing CT Stability Threshold for Subtle Lisfranc Injuries. Foot Ankle Int. 2025 Dec;46(12):1386-1394. doi: 10.1177/10711007251374674. Epub 2025 Oct 31.

    PubMed 41170783

Questions about this trial

What is this clinical trial studying?

A study testing Conservative treatment and Minimally invasive stabilization in people with Lisfranc Injury and Foot Sprain, run by Oslo University Hospital at 1 site in Norway.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 8 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 27 Jun 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Norway. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Manchester-Oxford Foot Questionnaire (MOxFQ) (time frame: 1 year). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT05799807, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 27 Jun 2024; AzTrials last refreshed its copy on 8 Nov 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in